dactinomycin has been researched along with phenytoin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| DeLuca, P; DeLuca, PP; Rusmin, S; Welton, S | 1 |
| Bittar, EE; Tallitsch, RB | 1 |
| Dalton, C; Hope, HR; Hope, WC; Sheppard, H | 1 |
| Gladner, JA; Houck, JC; Patel, YM; Sharma, VK | 1 |
| Das, KC; Hoffbrand, AV | 1 |
| Irwin, RP; Lin, SZ; Paul, SM; Weller, M; Wood, KA; Yan, GM | 1 |
| RAWSON, AJ; YANOFF, M | 1 |
1 review(s) available for dactinomycin and phenytoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for dactinomycin and phenytoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Effect of inline filtration on the potency of drugs administered intravenously.
Topics: Cephalothin; Dactinomycin; Dexamethasone; Digoxin; Drug Stability; Filtration; Infusions, Parenteral; Isoproterenol; Phenobarbital; Phenytoin | 1977 |
Mode of stimulation by aldosterone of the sodium efflux in barnacle muscle fibres: effects of ouabain, ethacrynic acid, diphenylhydantoin, (ATPMg)(2-), adenine translocase inhibitors, pyruvate and oxythiamine.
Topics: Adenosine Triphosphate; Aldosterone; Animals; Atractyloside; Biological Transport, Active; Bongkrekic Acid; Dactinomycin; Ethacrynic Acid; In Vitro Techniques; Muscles; Ouabain; Oxythiamine; Phenytoin; Phosphatidylserines; Pyruvates; Sodium; Spironolactone; Stimulation, Chemical | 1976 |
Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
Topics: Animals; Cholesterol; Clofibrate; Dactinomycin; DNA; Dose-Response Relationship, Drug; Glycolates; Hepatomegaly; Hypolipidemic Agents; In Vitro Techniques; Liver; Male; Microsomes, Liver; Mitochondria, Liver; Nafenopin; Oxidoreductases, N-Demethylating; Phenobarbital; Phenyl Ethers; Phenytoin; Phospholipids; Piperazines; Piperidines; Propionates; Proteins; Rats; RNA; Spectrophotometry, Ultraviolet; Triglycerides | 1974 |
Induction of collagenolytic and proteolytic activities by anti-inflammatory drugs in the skin and fibroblast.
Topics: Animals; Collagen; Culture Techniques; Cycloheximide; Dactinomycin; Depression, Chemical; Enzyme Induction; Fibroblasts; Glucuronidase; Hydrocortisone; Indomethacin; Male; Microbial Collagenase; Oxyphenbutazone; Peptide Hydrolases; Phenytoin; Puromycin; Rats; RNA; Skin; Stimulation, Chemical | 1968 |
Studies of folate uptake by phytohaemagglutinin-stimulated lymphocytes.
Topics: Adult; Anemia, Macrocytic; Anemia, Pernicious; Autoradiography; Biological Transport, Active; Carbon Isotopes; Cell Division; Culture Techniques; Dactinomycin; Folic Acid; Humans; Kinetics; Lectins; Lymphocyte Activation; Lymphocytes; Methotrexate; Phenytoin; RNA; Stimulation, Chemical; Temperature; Tritium | 1970 |
Diphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons.
Topics: Animals; Apoptosis; Calcium; Cells, Cultured; Cerebellum; Cycloheximide; Dactinomycin; DNA; Neurons; Phenytoin; Potassium; Rats; Rats, Sprague-Dawley | 1995 |
PELIOSIS HEPATIS. AN ANATOMIC STUDY WITH DEMONSTRATION OF TWO VARIETIES.
Topics: Anatomy; Chlorambucil; Classification; Cyclophosphamide; Dactinomycin; Femoral Fractures; Geriatrics; Liver Diseases; Mediastinal Neoplasms; Methotrexate; Neoplasm Metastasis; Norethandrolone; Parkinsonian Disorders; Pathology; Peliosis Hepatis; Phenytoin; Prostheses and Implants; Psychosurgery; Teratoma; Testosterone; Wound Healing | 1964 |